Sourcerock Group’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$134M Sell
14,553,804
-1,755,713
-11% -$19.6M 6.95% 3
2026
Q1
$177M Buy
16,309,517
+713,127
+5% +$6.1M 7.12% 5
2025
Q4
$95.3M Buy
15,596,390
+2,467,481
+19% +$14.7M 5.32% 7
2025
Q3
$68M Sell
13,128,909
-674,866
-5% -$3.88M 4.62% 7
2025
Q2
$81.9M Buy
13,803,775
+7,205,652
+109% +$43.4M 4.27% 11
2025
Q1
$54.2M Buy
6,598,123
+4,874,123
+283% +$40.9M 3.06% 10
2024
Q4
$14.2M Buy
+1,724,000
New +$13.8M 1.01% 20
2024
Q1
Sell
-768,583
Closed -$8.3M 36
2023
Q4
$8.3M Buy
+768,583
New +$9.34M 0.82% 18
2022
Q2
Sell
-1,156,760
Closed -$17.9M 24
2022
Q1
$17.9M Sell
1,156,760
-309,593
-21% -$3.91M 3.54% 9
2021
Q4
$12.4M Buy
+1,466,353
New +$12.6M 3.33% 9

Other funds holding PTEN

Sourcerock Group's PTEN Position: Q2 2026 in Review

Sourcerock Group reduced its Patterson-UTI (PTEN) stake by 11% in Q2 2026, selling an estimated $19.6M and leaving 14,553,804 shares worth $134M. The position accounts for 6.95% of the portfolio, ranked #3.

Sourcerock Group first reported a position in PTEN in Q4 2021 and has held it in 10 quarters since. The position peaked at $177M in Q1 2026. 437 funds tracked by Wall St. Rank hold PTEN as of Q2 2026.

  • Sourcerock Group held 14,553,804 shares of Patterson-UTI worth $134M as of Q2 2026.
  • Sourcerock Group sold 1,755,713 Patterson-UTI shares in Q2 2026, an estimated $19.6M.
  • Patterson-UTI made up 6.95% of Sourcerock Group's portfolio in Q2 2026, its #3 holding.
  • Sourcerock Group first reported a position in Patterson-UTI in Q4 2021 and has held it in 10 quarters since.
  • Sourcerock Group's Patterson-UTI position peaked at $177M in Q1 2026.
  • 437 funds tracked by Wall St. Rank held Patterson-UTI as of Q2 2026.

Based on Sourcerock Group's 13F filing for Q2 2026, filed 14 Aug 2026.